bioRxiv ScienceSearch

bioRxiv · 10.1101/2020.04.18.048397

A Fast High-Affinity Fluorescent Serotonin Biosensor Engineered from a Tick Lipocalin

Abstract

The authors have withdrawn their manuscript whilst they perform additional experiments to test some of their conclusions. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author. DetailsRegrettably, we, and several other researchers in the corresponding authors lab and not involved in the original study, have been unable to reproduce some of the reported key results under conditions originally described. We recently used the pDisplay-G-GESS-M plasmid to transfect HEK 293T cells and observed that the membrane localization of the biosensor was sensitive to FBS batches. By using an FBS batch from Gibco (Cat# 16000-044 and Lot #2103017RP), we were able to replicate the membrane localization similar to what was reported in Fig. 1e. However, the cells required the addition of several hundred micromolar of serotonin for robust fluorescence increase. These new results suggest that the affinity of G-GESS to serotonin is worse than that claimed in the initial article. We further used liquid chromatography-mass spectrometry (LC-MS) to analyze the serotonin stock solutions identified in our -80{degrees}C lab freezer and observed MS peaks suggesting a glutamate contamination in some of the analyzed samples. In addition, we used polymerase chain reaction (PCR) or reverse transcription-PCR (RT-PCR) to amplify gene fragments from our viral stocks and the sequencing results indicate that the viral stocks were contaminated with a glutamate biosensor. While we are still performing further investigation, in light of the existing findings, all authors agree to retract this paper. In the initial article, the sensor was tested in several cell culture systems, brain slices and behaving mice. We are presently unable to fully explain the observed sensor responses described in the initial article, but it is highly possible that these responses could be caused by the contaminated chemical or viral stocks. We deeply apologize to the scientific community for not detecting these problems sooner.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, S., Li, X., Drobizhev, M., Ai, H.. 2020-04-20. A Fast High-Affinity Fluorescent Serotonin Biosensor Engineered from a Tick Lipocalin. https://doi.org/10.1101/2020.04.18.048397

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience